Stay In The Know
Join The Discord & Study Up With The Foundation Video Series https://tradejournal.co/connect
News
Live Stream
Timestamps in video description
Notes / Research / Recap / Additional Video
SPCX - space etf
ACAC merging soon with PlayStudios
TRCH
@alexwinkler the 10% discount code for Annette’s 420 art is live for Team Winkler on my website. It’s “AWinkler”
https://www.jeffthe420chef.com/shop?Product+Type=420+Art
SFTW SPAC taking BlackSky public
PSTH
QUIK Stock I broke a rule which is don't trade a ticker that has yet to prove it can hold it's highs.
Mixed vol code https://tos.mx/H582pK
kyle GreatA. Winkler shirt- looks like a jersey, and on the back where the name would go, “tricky tickler"
Nicholas Pya know i only know him(wolf of weed st) from the TTG channel... ik he is active on twitter
Watchlist
| MTC [NASD] |
| Mmtec, Inc. |
| Technology | Software - Application | China |
65% 80mc 8f
??
| Oct-15-20 06:00PM |
PR Newswire -15.67%
|
| Aug-17-20 07:30AM |
| JMP [NYSE] |
| JMP Group LLC |
| Financial | Capital Markets | USA |
65% 100mc 8f
| Feb-18-21 04:15PM | |
| Feb-16-21 04:15PM |
| WATT [NASD] |
| Energous Corporation |
| Technology | Scientific & Technical Instruments | USA |
60% 162mc 42f
04:50 PM EST, 02/18/2021 (MT Newswires) -- JMP Group (JMP) on Thursday reported Q4 operating earnings of $0.42 per diluted share, up from $0.01 a year ago.
Revenue increased to $53.6 million from $23.8 million.
Price: 8.2100, Change: +3.24, Percent Change: +65.19
| Feb-04-21 06:30AM | |
| Jan-06-21 06:05AM |
| TAOP [NASD] |
| Taoping Inc. |
| Technology | Software - Infrastructure | China |
96% 50mc 6f
SHENZHEN, Feb. 19, 2021 (GLOBE NEWSWIRE) -- Taoping Inc. (NASDAQ: TAOP, the “Company”), a provider of internet-based smart display screens, and a new-media ecosystem that enables targeted advertising and online retail, announced today that the Company has entered into a consulting agreement (the "Consulting Agreement") with Great Bay Capital Investment Limited ("Great Bay").
Pursuant to the Consulting Agreement, TAOP engaged Great Bay as a consultant for a two-year term effective February 19, 2021. Great Bay will provide various consulting services including the following:
- Provide the Company with business development services focused on blockchain and digital assets (such as Bitcoin, Ethereum, etc.) investment opportunities.
- Introduce TAOP to potential investors for strategic investment.
- Introduce potential M&A targets in blockchain industry, and assist TAOP in completing relevant due diligence work and propose M&A plans.
| Jan-26-21 08:30AM | |
| Jan-20-21 08:30AM |
GlobeNewswire
|
| VCNX [NASD] |
| Vaccinex, Inc. |
| Healthcare | Biotechnology | USA |
50% 63mc 18f
Vaccinex Announces Signing of Two Multi-Project Deals with Leading Pharmaceutical Companies Focused on Leveraging Its ActivMAb® Platform
ROCHESTER, N.Y., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced the signing of multi-project deals with two undisclosed prominent pharmaceutical companies. The collaborations will focus on using ActivMAb®, Vaccinex’s antibody discovery and novel viral display platform, for antibody discovery against complex antigens such as GPCRs and ion channels. Financial terms of the deals are undisclosed.
“Our ActivMAb platform has delivered numerous promising antibody-based solutions for complex therapeutic targets, both for our own R&D efforts and those of our partners,” said Ernest Smith, chief scientific officer of Vaccinex. “These two collaboration agreements with prominent pharmaceutical companies underscore ActivMAb’s unique ability to discover promising antibodies against challenging molecules with tangible R&D value. We look forward to working closely with our partners to develop potential treatments specific for such previously hard to drug targets.”
ActivMAb was developed by Vaccinex and is a proprietary mammalian cell-based antibody discovery platform. The technology has multiple applications, including discovery of antibodies specific for complex membrane antigens, discovery of antibodies with optimized developability, and protein optimization for expression and activity. Its novel capabilities enable selection of unique antibody drugs against difficult high-value targets, including multi-pass membrane proteins against which small molecule drugs have demonstrated low efficacy or high toxicity.
| Jan-07-21 08:19AM | |
| Jan-06-21 08:43AM |
Free Gap Scanner + Win 2 Free Stocks 🎉 (Each Up To $1600) 👉👉 http://enzlo.com/webull
Best Savings Account Ever! 😍 Win $10 Million - Use Code: WINKLER 👉👉 http://enzlo.com/save
Watchlist 👉👉 https://tradejournal.co/post/friday-pre-market-top-gainers-417/